Clinical trial
Lamotrigine Extended-Release in Elderly Patients With Epilepsy
NCT00516139 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lamotrigine Extended-Release in Elderly Patients With Epilepsy
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- July 31, 2010
- Enrollment
- 122 (actual)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.